Cargando…
Jakinibs of All Trades: Inhibiting Cytokine Signaling in Immune-Mediated Pathologies
Over the last 25 years, inhibition of Janus kinases (JAKs) has been pursued as a modality for treating various immune and inflammatory disorders. While the clinical development of JAK inhibitors (jakinibs) began with the investigation of their use in allogeneic transplantation, their widest successf...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779366/ https://www.ncbi.nlm.nih.gov/pubmed/35056105 http://dx.doi.org/10.3390/ph15010048 |